Form D · Other Health Care
Verismo Therapeutics, Inc.
Philadelphia, PA · CIK 0001855431
Offering snapshot reported May 20, 2026 · SEC filing
- Reported sold
- $28M Offering amount: $28M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 21, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 20, 2026 | Initial | $28,000,000 | No comparison | 1 | SEC filing |
| Jul 14, 2023 | Initial | $19,150,012 | No comparison | 7 | SEC filing |
| Apr 27, 2021 | Initial | $16,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-584655
Source: Form D, filed May 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hyuk Joo Jee | Director |
| Yang Gon Jin | Director |
| Gene Kim | Executive |
| Bryan B. Kim | Director, Executive |
| Dong Gun Kim | Director |
| Jong Sun Yoon | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3675 Market Street, Suite 200
Philadelphia, PA, 19104
Philadelphia, PA, 19104